TY - JOUR T1 - Covid-19 clinical data analysis using Ball Mapper JF - medRxiv DO - 10.1101/2020.04.10.20061374 SP - 2020.04.10.20061374 AU - Pawel Dlotko AU - Simon Rudkin Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/15/2020.04.10.20061374.abstract N2 - In this note we provide a result of analysis of blood test data from patients with SARS-Cov-2 using Ball Mapper Algorithm. We observe that patients with the virus and in particularly patients who end up in Intensive Care Unit have quite narrow values of those parameters. Please note that this is a preliminary work and it need to be validated on much larger dataset which we are trying to acquire at the moment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPD. is supported by EPSRC grant New Approaches to Data Science: Application Driven Topological Data Analysis EP/R018472/1Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available via Kagle link provided in the paper. ER -